Species and pathway-specific activation of complement by a phosphorothioate oligonucleotide

Author： Henry S.   Jagels M.   Hugli T.   Giclas P.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 97-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pathway-Specific, Species, and Sub-Type Counterscreening for Better GPCR Hits in High Throughput Screening

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 7, 2010-11 ,pp. : 757-763

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of complement mediators on eosinophil activation

By DiScipio R.G.   Sriramarao P.   Schraufstatter I.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 93-93

Elsevier

Access to resources Recommend Favorite

Properdin and Complement Activation: A Fresh Perspective

By  

Current Drug Targets, Vol. 9, Iss. 2, 2008-02 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Modulators of complement activation: a patent review (2008 – 2013)

By Larghi Enrique L   Kaufman Teodoro S  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 665-686

Informa Healthcare

Access to resources Recommend Favorite

Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement

By Pangburn M.K.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite